Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
Tags: oraquick | home | hiv | test

Experts: Home HIV Testing has Little Impact

Wednesday, 10 October 2012 04:43 PM EDT

OraQuick — the new over-the-counter, home-based HIV test — is not likely to reduce transmission of the AIDS virus or lower the barriers to care for people infected with the disease, according to a new report by leading AIDS experts.
The report, published online in Annals of Internal Medicine, is not a “game changer” in the fight against HIV, despite the widespread media hype surrounding its availability.
With its high cost, the test is likely to attract primarily affluent consumers at low risk for infection, they concluded. People most at risk for infection, and those with diagnosed HIV seeking to find out if treatment has improved their health, are not likely to use the test or benefit as much.
As a result, the report’s authors — A. David Paltiel, a professor of public health and management sciences at Yale University, and Rochelle Walensky, an associate professor of medicine at Massachusetts General Hospital — said routine screening in doctors’ offices and clinics is the best way to identify and care for the estimated 235,000 Americans who don’t know they are infected with HIV.
They added that home testing is not a substitute for routine HIV screening in a professional healthcare setting.
“A $40 home HIV test is not even likely to make an appreciable dent in the number of undetected HIV infections,” they said. “Rather, it will attract a predominantly affluent clientele composed of persons at low risk for HIV infection, persons with very recent high-risk exposures, and persons with known HIV infection seeking to monitor therapy or to pursue a misperception that treatment has reversed their seropositivity.”
Last July, U.S. regulators approved OraQuick — the first rapid, at-home HIV screening test. The saliva test gives results within 40 minutes without a doctor or laboratory.

© HealthDay

The new OraQuick home-based HIV test is not likely to have much impact in the fight against AIDS, experts say.
Wednesday, 10 October 2012 04:43 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
You May Also Like
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved